Table 2 Mortality hazard ratios for women diagnosed with breast cancer between 2005 and 2011 and receiving HCAI care only and some HCAI care compared with other London women

Other London women

1.00

1.00

1.00

1.00

1.00

1.00

HCAI care only

0.48 (0.32, 0.74)

0.66 (0.43, 1.02)

0.70 (0.46, 1.08)

0.70 (0.45, 1.07)

0.72 (0.47, 1.10)

0.79 (0.51, 1.21)

Some HCAI care

0.24 (0.14, 0.41)

0.32 (0.19, 0.54)

0.34 (0.20, 0.58)

0.35 (0.21, 0.59)

0.40 (0.24, 0.67)

0.48 (0.28, 0.80)

χ ²-test (2 d.f.)

39.35

21.69

18.40

18.30

14.03

8.83

p-heterogeneity

<0.0001

<0.0001

<0.0001

0.0001

0.0009

0.0121

 <40

1.00

1.00

1.00

1.00

1.00

 40-44

0.85 (0.72, 1.01)

0.86 (0.73, 1.02)

0.86 (0.73, 1.02)

0.88 (0.74, 1.03)

0.96 (0.81, 1.13)

 45-49

0.77 (0.65, 0.89)

0.78 (0.67, 0.91)

0.78 (0.67, 0.92)

0.81 (0.70, 0.95)

0.89 (0.76, 1.04)

 50-54

0.65 (0.56, 0.77)

0.67 (0.57, 0.78)

0.67 (0.57, 0.78)

0.78 (0.66, 0.91)

0.86 (0.74, 1.01)

 55-59

0.83 (0.72, 0.97)

0.86 (0.74, 1.00)

0.85 (0.74, 0.99)

0.97 (0.84, 1.13)

1.11 (0.95, 1.29)

 60-64

0.85 (0.73, 0.99)

0.88 (0.76, 1.02)

0.88 (0.76, 1.02)

1.06 (0.91, 1.23)

1.27 (1.10, 1.48)

 65-69

1.05 (0.91, 1.21)

1.08 (0.93, 1.25)

1.08 (0.93, 1.24)

1.30 (1.12, 1.50)

1.65 (1.42, 1.91)

 70-74

2.01 (1.74, 2.30)

2.07 (1.80, 2.39)

2.07 (1.80, 2.38)

2.24 (1.95, 2.58)

2.83 (2.45, 3.27)

 75-79

2.85 (2.49, 3.26)

2.94 (2.57, 3.36)

2.94 (2.57, 3.36)

3.08 (2.69, 3.53)

3.91 (3.40, 4.50)

 80+

6.19 (5.48, 6.99)

6.41 (5.67, 7.24)

6.42 (5.69, 7.26)

6.10 (5.40, 6.89)

6.87 (6.03, 7.82)

χ ²-test (1 d.f.)

2,755.90

2,804.15

2,804.01

2,540.64

2,052.19

p-trend

<0.0001

<0.0001

<0.0001

<0.0001

<0.0001

 1 = Affluent

1.00

1.00

1.00

1.00

 2

0.97 (0.88, 1.07)

0.96 (0.87, 1.06)

0.97 (0.87, 1.07)

0.97 (0.87, 1.07)

 3

1.06 (0.96, 1.16)

1.05 (0.96, 1.15)

1.04 (0.95, 1.15)

1.04 (0.95, 1.14)

 4

1.18 (1.08, 1.29)

1.18 (1.08, 1.29)

1.19 (1.09, 1.30)

1.16 (1.07, 1.27)

 5 = Deprived

1.37 (1.26, 1.49)

1.36 (1.25, 1.48)

1.27 (1.17, 1.38)

1.22 (1.12, 1.33)

χ ²-test (1 d.f.)

92.81

92.14

61.05

44.50

p-trend

<0.0001

<0.0001

<0.0001

<0.0001

 2005

1.00

1.00

1.00

 2006

0.99 (0.91, 1.07)

1.08 (0.99, 1.17)

1.08 (1.00, 1.17)

 2007

1.00 (0.92, 1.09)

1.10 (1.02, 1.20)

1.07 (0.98, 1.16)

 2008

0.98 (0.89, 1.06)

1.11 (1.01, 1.21)

1.02 (0.93, 1.11)

 2009

0.87 (0.79, 0.96)

0.93 (0.85, 1.03)

0.87 (0.80, 0.96)

 2010

0.81 (0.73, 0.90)

0.82 (0.74, 0.91)

0.84 (0.76, 0.93)

 2011

0.74 (0.65, 0.84)

0.81 (0.72, 0.92)

0.83 (0.73, 0.94)

χ ²-test (1 d.f.)

33.22

22.52

27.02

p-trend

<0.0001

<0.0001

<0.0001

 1

1.00

1.00

 2

1.02 (0.94, 1.11)

1.10 (1.01, 1.19)

 3

2.28 (2.07, 2.51)

2.27 (2.06, 2.51)

 4

6.37 (5.89, 6.90)

4.90 (4.52, 5.31)

 Not known

2.67 (2.47, 2.88)

1.82 (1.68, 1.96)

χ ²-test (1 d.f.)

2,924.02

1,630.20

Excl. NK p-trend

<0.0001

<0.0001

 No

1.00

 Yes

0.82 (0.77, 0.89)

χ ²-test (1 d.f.)

28.19

p-heterogeneity

<0.0001

 No

1.00

 Yes

1.29 (1.20, 1.38)

χ ²-test (1 d.f.)

50.87

p-heterogeneity

<0.0001

 No

1.00

 Yes

0.40 (0.37, 0.42)

χ ²-test (1 d.f.)

962.80

p-heterogeneity

<0.0001

 No

1.00

 Yes

0.80 (0.75, 0.85)

χ ²-test (1 d.f.)

58.07

p-heterogeneity

<0.0001